Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

481
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
481
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

851
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
851
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

447
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
447
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

266
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
266
Stimulants01:29

Stimulants

574
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
574
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

1.8K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning and natural language processing for the identification of potential mental disorders among school-age children: a prospective birth cohort study.

BMC medicine·2026
Same author

Cortical similarity networks in the rat brain: Postnatal development and sensitivity to early life stress.

Network neuroscience (Cambridge, Mass.)·2026
Same author

Peripheral inflammation is associated with reduced influx of TSPO PET tracers into the brain: insights from a non-invasive mapping methodology.

Brain, behavior, and immunity·2026
Same author

Commercial or industrial use of mental health data for research: primer and best-practice guidelines from the DATAMIND patient/public Lived Experience Advisory Group.

Frontiers in psychiatry·2026
Same author

Network-based disease fingerprinting with neuroinflammation PET imaging.

Journal of neuroinflammation·2026
Same author

Genetic insights on the mechanisms of human cortical folding.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Oct 31, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.5K

Impaired Learning From Negative Feedback in Stimulant Use Disorder: Dopaminergic Modulation.

Tsen Vei Lim1, Rudolf N Cardinal1,2, Edward T Bullmore1,2

  • 1Department of Psychiatry, University of Cambridge, Cambridge, UK.

The International Journal of Neuropsychopharmacology
|July 1, 2021
PubMed
Summary
This summary is machine-generated.

Stimulant use disorder (SUD) impairs punishment-based learning, linked to dopamine system alterations. Dopamine D2/3 receptor agents differentially modulated reinforcement learning (RL) in SUD patients and healthy controls.

Keywords:
Addictioncocainehierarchical Bayesian modelingpunishmentreinforcement learningreward

More Related Videos

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.7K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.1K

Related Experiment Videos

Last Updated: Oct 31, 2025

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

15.5K
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
09:43

Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats

Published on: October 5, 2021

2.7K
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

26.1K

Area of Science:

  • Neuroscience
  • Computational Psychiatry
  • Addiction Research

Background:

  • Stimulant use disorder (SUD) is associated with dopamine system alterations.
  • These alterations are hypothesized to impair reinforcement learning (RL).
  • Computational modeling offers a method to investigate RL processes in SUD.

Purpose of the Study:

  • To investigate reinforcement learning (RL) in individuals with SUD.
  • To determine the modulatory role of dopamine D2/3 receptors in RL.
  • To examine if dopamine receptor agents differentially affect RL in SUD patients.

Main Methods:

  • Utilized a probabilistic RL task assessing reward and punishment learning in 44 SUD patients and 41 controls.
  • Administered dopamine D2/3 receptor antagonist (amisulpride) and agonist (pramipexole) in a randomized, double-blind, placebo-controlled crossover study.
  • Applied computational modeling to analyze task performance and RL parameters.

Main Results:

  • SUD patients exhibited significantly reduced learning rates from punishment compared to controls; reward learning rates were unimpaired.
  • Dopamine receptor agents differentially modulated RL parameters in both groups.
  • Amisulpride and pramipexole impaired RL in healthy participants but improved punishment learning in SUD patients.

Conclusions:

  • Reinforcement learning impairments in SUD are linked to altered dopamine function.
  • Dopamine D2/3 receptor modulation offers potential therapeutic avenues for SUD-related learning deficits.